The CAR-TCR 2019 Summit will be held on September 10-13, 2019 in Boston, Massachusetts.
André Choulika, Ph.D., Chairman and Chief Executive Officer of Cellectis, will participate in this event on Wednesday, September 11 from 9:00-10:00 AM EDT during an Industry Leader's Fireside Chat about CAR-T therapies.
David Sourdive, Ph.D., Executive Vice President, Technical Operations at Cellectis, will participate in this event on Thursday, September 12 from 12:30-1:00 PM EDT during a manufacturing panel titled, "Streamline Manufacture to Reduce CoG & Ensure Timely Delivery." He will also be presenting the same day at 4:36-5:06 PM EDT with a presentation titled, "Manufacturing Concepts for Gene-Edited Allogeneic CAR-T Cell Products."
Elsy Boglioli, Chief Operating Officer at Cellectis, will participate in this event on Thursday, September 12 from 12:30-1:00 PM EDT during a commercialization panel titled, "How Partnerships Can Accelerate Product Development & Commercialization."
Alexandre Juillerat, Ph.D., U.S. Laboratory Head and Team Leader at Cellectis, will present at this event on Friday, September 13 from 9:00-9:30 PM EDT with a presentation titled, "Defining the Future of CAR-T Cells through Genetic Engineering."
Ariane Hamaide, VP Corporate Development at Cellectis, will participate in the event on Tuesday, September 10 at 6:00 PM EDT in the Women of CAR-TCR Expert Roundtable.